DrugLogic Inc. Announces Roll out of Qscan Version 3.RESTON, Va. -- DrugLogic(TM), Inc. is pleased to announce Qscan(TM) Version 3 to be rolled out later this summer for all current Qscan(TM) implementations; Qscan(TM) PRO (proprietary data application) as well as Qscan(TM) FDA FDA
Food and Drug Administration
n.pr See Food and Drug Administration.
n.pr the abbreviation for the Food and Drug Administration. (FOI FOI Freedom Of Information
FOI Totalförsvarets Forskningsinstitut (Swedish Defence Research Agency)
FOI The Swedish Defence Research Agency
FOI Field of Interest
FOI Full of It
FOI Fruit of Islam , AERS AERS Adverse Event Reporting System (database of drug adverse reactions)
AERS Association of Educators in Radiological Sciences
AERS Army Educational Requirements System
AERS Acute Equine Respiratory Syndrome
AERS Access/Egress Roadway System data) and Qscan(TM) World (WHO-UMC data). Qscan(TM) is DrugLogic's flagship product A primary product of a company, which is typically why the company was founded and/or what made it well known. For example, MS-DOS, Windows and the Microsoft Office suite have been flagship products of Microsoft. CorelDRAW is a flagship product of Corel Corporation. used to monitor and analyze both drug company proprietary adverse event data and publicly available data. New features of version 3 will be demonstrated at the International Society for Pharmacoepidemiology (ISPE ISPE International Society for Pharmaceutical Engineering
ISPE International Society for Pharmacoepidemiology
ISPE Institute for the Study of Planet Earth (University of Arizona, Tucson, AZ)
ISPE International Society of Pharmaceutical Engineers ) conference in Bordeaux 22-25 August.
Version 3 of Qscan(TM) incorporates improvements that provide a dramatic increase in performance, by a factor of 10 to 20, and adds an extensive array of new functions to support data mining, data browsing See browse. and collaborative workgroup activities. The new architecture for Qscan, with several patents pending, has been completely revamped to provide the user the ability to control queries and presentations "on-the-fly" with real time multi-dimensional displaying and execution of analysis. The list of new function included in Qscan(TM) Version 3 enhances every aspect of Qscan search and analytics and includes:
-- A new custom reporting system -- An intuitive Boolean logic screen, to create the complex searches needed for drug cocktails syndromes, and user defined dimensions -- A batch series engine that can be applied to ALL other engines, to create times series, drug comparisons, and custom side by side comparisons -- Options for stratification in proportional analysis for ALL algorithms -- A new statistic, the Information Component (IC) of the BCPNN, and the attendant confidence intervals -- Two-dimensional displays and graphing to allow user defined presentations such as reactions and outcomes against age, gender or concomitant drugs -- Associations, stratification, re-profiling, and many others
Version 3 adds an extensive custom reporting system that gives the user complete control over format of the text, graphs and tables of the report. The basis of the report system is a simple file saving and "media bin" concept. Reports are created using an innovative storyboard A sequence of images and annotations for a cartoon, animation or video. Storyboards are previews of the final version and typically contain mockups rather than final art and images. Before computers, storyboards were drawn with pen and ink on lightweight cardboard. paradigm that allows the user to assemble each piece of the report, annotate annotate - annotation charts and tables, add text pages and then print or save the report. Qscan's report system is integral to the application and will not require any external license.
A new home page has been devised to pull together these new features, saving the user many steps to accomplish sophisticated and complex data analysis in a simple and rapid way. The command page is also the launch point for collaborative project management and for the new storyboard oriented o·ri·ent
1. Orient The countries of Asia, especially of eastern Asia.
a. The luster characteristic of a pearl of high quality.
b. A pearl having exceptional luster.
3. custom reporting system.
The Qscan version 3 will provide a new level of capability in pharmacovigilance and research. The application to drug safety, clinical trials and basic discovery will be further enhanced over time, as it has been in the past. These improvements will be provided free of additional charge to subscribers of Qscan in its various implementations.
About DrugLogic Inc.
DrugLogic(TM) Inc. specializes in developing analytical tools for managing risks related to drug safety issues. DrugLogic is dedicated to designing, developing and delivering products that provide the latest innovations and state-of-the art solutions in support of pharmacovigilance and drug safety surveillance practices for both pharmaceutical and biotech bi·o·tech
short for biotechnology
Noun 1. companies. Its proprietary Qscan(TM) product monitors both company proprietary adverse event data and publicly available data sources. For more information, visit www.druglogic.com.